Publicaciones (61) Publicaciones de INES SUAREZ GARCIA

2023

  1. Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 6, pp. 1423-1432

  2. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171

  3. Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  4. Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.

    European Journal of Internal Medicine, Vol. 110, pp. 54-61

  5. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

  6. Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV

    HIV Medicine, Vol. 24, Núm. 6, pp. 727-737

  7. Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006–2021

    Enfermedades Infecciosas y Microbiologia Clinica

2022

  1. Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort

    Journal of Acquired Immune Deficiency Syndromes, Vol. 90, Núm. 1, pp. 62-68

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Frequency and characteristics of HTLV in migrants: results from the +Redivi collaborative network in Spain

    Journal of travel medicine, Vol. 29, Núm. 7

  4. Past and future of HIV infection. A document based on expert opinion

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 131-156

  5. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  6. Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

    Journal of Infection

  7. Temporal Trends and Geographic Variability in the Prescription of Antiretroviral Treatments in People Living with HIV in Spain, 2004–2020

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  8. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

    Microorganisms, Vol. 10, Núm. 2

  9. Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

    AIDS Research and Human Retroviruses, Vol. 38, Núm. 6, pp. 433-440

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in a multicentre cohort in Spain

    Journal of the International AIDS Society, Vol. 24, Núm. 7

  3. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

    BMC women's health, Vol. 21, Núm. 1, pp. 223

  4. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792